Sponsor or institution

Clinical trials and research at Tang-Du Hospital

• 36Clinical trials
• 1Country

Newest trials

All recruiting trials (36)

• Multi-Field-Strength Brain MRI Atlas for Healthy Chinese Adults

  This study tests how brain measurements vary across MRI strengths (0.55T to 7T) in healthy Chinese adults to build standard brain templates.

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT07786233

• Stent-assisted Coil Embolization for Acute Ruptured Intracranial Aneurysms

  This study tests whether stent-assisted coil embolization for ruptured intracranial aneurysms can be safely used in the acute period and help prevent rebleeding.

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT07683377

• Gut–brain gut study in IBS with anxiety and depression

  This study will compare people with IBS and mood symptoms to healthy volunteers to see if gut bacteria relate to brain function using questionnaires, stool and blood samples, and a brain MRI.

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT07646834

• How Saline Infusion Sonohysterography Helps Assess Cesarean Scar Defects

  This study tests whether saline infusion sonohysterography can reliably detect cesarean scar defects and guide treatment for people experiencing symptoms after cesarean delivery.

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT07610668

• Serplulimab Monotherapy in Elderly NSCLC Patients with High PD-L1 (≥50%)

  This study tests whether serplulimab alone can help older adults with NSCLC who have high PD-L1 levels (≥50%).

  Recruiting Phase 2 Tang-Du Hospital · Xi'an, Shannxi · NCT07596121

• Injecting methylprednisolone into the artery right after clot removal for large-vessel stroke

  This trial will test whether giving methylprednisolone into the artery immediately after successful clot removal, followed by three days of IV methylprednisolone, helps adults with anterior large-vessel occlusion strokes recover better.

  Recruiting Phase 2 Tang-Du Hospital · Xi'an, Shaanxi · NCT07516522

• Fully resorbable drug‑eluting sinus stent for eosinophilic nasal polyps after surgery

  This trial tries a fully resorbable drug-releasing sinus stent in adults with eosinophilic chronic rhinosinusitis with nasal polyps after surgery or with early polyp return to see if it lowers polyp recurrence and reduces the need for oral steroids.

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT07498374

• How anticoagulant medicines affect the uterine lining and pregnancy chances in women with infertility

  This study will see if routine anticoagulant medicines like low-dose aspirin or heparin change endometrial receptivity and improve early pregnancy outcomes in women aged 20–45 with infertility.

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT07494877

• Transcutaneous auricular vagus nerve stimulation for depression after heart procedures

  This study tests whether at-home taVNS can help reduce depressive symptoms in adults 18–80 who recently had PCI for ACS.

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT07454070

• Time-of-Day of Immunotherapy Infusion with Chemotherapy for Thoracic Esophageal Squamous Cell Carcinoma

  Researchers are testing if the time of day when the immunotherapy is given affects the success of treatment for resectable thoracic ESCC in combination with chemotherapy.

  Recruiting Phase 2 Tang-Du Hospital · Xi'an, Shannxi · NCT07452601

• Ivonescimab with albumin‑paclitaxel and cisplatin before surgery for esophageal squamous cell carcinoma

  This trial tests whether adding ivonescimab to albumin‑paclitaxel and cisplatin before surgery helps people with resectable, locally advanced esophageal squamous cell carcinoma.

  Recruiting Phase 1/2 Tang-Du Hospital · Xi'an, Shannxi · NCT07385001

• Noninvasive transcranial temporal interference stimulation for neuropathic pain in NMOSD

  Researchers will try noninvasive transcranial temporal interference stimulation to reduce chronic neuropathic pain in adults with neuromyelitis optica spectrum disorder (NMOSD).

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT07377305

• Neoadjuvant ensartinib plus chemotherapy for resectable ALK-positive NSCLC

  This will test whether taking ensartinib with chemotherapy before surgery helps people with stage II–IIIB (N2) ALK-positive, resectable non-small cell lung cancer.

  Recruiting Phase 1/2 Tang-Du Hospital · Xi’an, Shanxi · NCT07354061

• Nimotuzumab plus toripalimab and chemotherapy for locally advanced tonsillar cancer

  This trial will try giving nimotuzumab and toripalimab together with chemotherapy before surgery to see if it increases complete tumor response in people with resectable, locally advanced tonsillar cancer.

  Recruiting Phase 2 Tang-Du Hospital · Shanxi, Province · NCT07353723

• Methylprednisolone given into the artery and IV after thrombectomy for anterior large-vessel stroke

  This trial tests whether giving intra-arterial methylprednisolone immediately after a successful thrombectomy followed by three days of IV methylprednisolone helps people with acute anterior large-vessel ischemic stroke recover better.

  Recruiting Phase 3 Tang-Du Hospital · Xi'an, Shaanxi · NCT07141303

• Adebrelimab plus etoposide capsules as maintenance therapy for extensive-stage small cell lung cancer

  This phase 2 trial will test whether adebrelimab combined with etoposide capsules as maintenance therapy helps people with extensive-stage small cell lung cancer who had no progression after initial platinum-based chemotherapy with adebrelimab.

  Recruiting Phase 2 Tang-Du Hospital · Xi'an, Shannxi · NCT07141264

• Semi-elemental tube feeding to improve gut tolerance after severe traumatic brain injury

  This will test whether starting semi-elemental tube feeding within 48 hours reduces gastrointestinal intolerance in adults with severe traumatic brain injury.

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT07092423

• Using engineered stem cell exosomes to treat thin endometrial lining in women

  This study tests if a new treatment using special stem cell particles can help women with a thin uterine lining get thicker linings compared to standard treatments.

  Recruiting at 2 sites Phase 1/2 Tang-Du Hospital · Xi'an, Shaanxi and 1 other locations · NCT06896747

• Treatment of lung cancer with sunvozertinib

  This study is testing if a new drug called sunvozertinib can help people with stage II-IIIB non-small-cell lung cancer who have a specific genetic mutation feel better and improve their treatment outcomes.

  Recruiting Phase 2 Tang-Du Hospital · Changsha, Hunan and 2 other locations · NCT06864624

• Comparing 2 vs 4 cycles of Adebrelimab for esophageal cancer treatment

  This study is testing whether getting 2 or 4 cycles of a new treatment combined with chemotherapy can help people with advanced esophageal cancer respond better before surgery.

  Recruiting Phase 2 Tang-Du Hospital · Xi'an, Shannxi · NCT06663059

• Method to identify intersegmental planes in lung cancer surgery

  This study tests a new method to help doctors find the right areas to remove during lung cancer surgery, aiming to improve outcomes for patients with small tumors.

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT06644066

• Using Adebrelimab with chemotherapy for early-stage small cell lung cancer

  This study is testing if adding Adebrelimab to chemotherapy helps people with early-stage small cell lung cancer do better before surgery compared to just chemotherapy alone.

  Recruiting Phase 2 Tang-Du Hospital · Xi'an, Shannxi · NCT06485544

• Combining Adebrelimab and Apatinib for Small Cell Lung Cancer Maintenance

  This study is testing if a combination of two drugs, Adebrelimab and Apatinib, can help people with extensive-stage small cell lung cancer stay healthy after their initial chemotherapy.

  Recruiting Phase 2 Tang-Du Hospital · Xi'an, Shannxi · NCT06475209

• Therapeutic effects of irinotecan liposomes for small cell lung cancer

  This study is testing if a new treatment using irinotecan liposomes can help people with small cell lung cancer who haven't responded to their first treatment feel better and live longer.

  Recruiting Phase 4 Tang-Du Hospital · Xi'an, Shannxi · NCT06467786

• Evaluating a new CAR-T therapy for severe Myasthenia Gravis

  This study is testing a new CAR-T therapy to see if it can help adults with severe myasthenia gravis who haven't found relief from standard treatments.

  Recruiting Phase 1 Tang-Du Hospital · Xi'an, Shaanxi · NCT06371040

• Combining taurine with chemotherapy and immunotherapy for advanced gastric cancer treatment

  This study is testing if adding taurine to chemotherapy and immunotherapy can help people with advanced gastric cancer feel better and improve their treatment results.

  Recruiting at 15 sites Tang-Du Hospital · Wuhan, Hubei and 14 other locations · NCT06128252

• Baricitinib for moderate-to-severe intracerebral bleeding and contusions after head injury

  This will test whether giving baricitinib soon after a head injury helps adults with moderate to severe brain bleeding or contusions recover better.

  Recruiting Phase 2 Tang-Du Hospital · Xi'an, Shaanxi · NCT06065046

• Combining Zimberelimab with Paclitaxel and Cisplatin for Cervical Cancer Treatment

  This study is testing if a new treatment combining Zimberelimab with two chemotherapy drugs can help women with advanced cervical cancer shrink their tumors before surgery.

  Recruiting Phase 2 Tang-Du Hospital · Xi'an, Shaanxi · NCT06055738

• Neoadjuvant therapy for resectable esophageal squamous cell carcinoma

  This study is testing if a new combination of treatments can help people with operable esophageal cancer do better than the usual chemotherapy before surgery.

  Recruiting at 3 sites Phase 2 Tang-Du Hospital · Xi'an, Shaanxi and 2 other locations · NCT06006650

• Ofatumumab for AQP4‑antibody positive neuromyelitis optica spectrum disorder

  This pilot will try ofatumumab, a human anti‑CD20 antibody, in adults with AQP4‑IgG positive NMOSD who have had recent relapses to see if it reduces relapses and is safe.

  Recruiting Phase 1/2 Tang-Du Hospital · Xi'an, Shaanxi · NCT05504694

• Exploring cognitive impairment in breast cancer patients

  This study is trying to see if certain brain changes in young women with breast cancer who are undergoing chemotherapy and hormone therapy can help predict memory and thinking problems, so doctors can choose better treatment plans.

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT05305092

• Using Tocilizumab to treat Generalized Myasthenia Gravis

  This study is testing if Tocilizumab can help people with Generalized Myasthenia Gravis who have anti-AChR antibodies feel better and improve their symptoms.

  Recruiting Phase 2 Tang-Du Hospital · Beijing, Beijing Municipality and 5 other locations · NCT05067348

• Monitoring intracranial pressure in patients with moderate traumatic brain injury

  This study is testing if keeping track of pressure inside the skull can help people with moderate traumatic brain injury in China recover better compared to those who don't have this monitoring.

  Recruiting Tang-Du Hospital · Xi'an, Shannxi Province · NCT04900168

• Assessing the risk of cerebrovascular disease in patients with carotid stenosis

  This study is testing new ways to see if people with asymptomatic carotid stenosis have different thinking skills and stroke risks compared to healthy individuals.

  Recruiting Tang-Du Hospital · Xi'an · NCT04443439

• Different immunosuppressants and treatments for new-onset ocular myasthenia gravis

  This project tries different immunosuppressants and symptomatic treatments to see which works best and is safest for adults with new-onset ocular myasthenia gravis.

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT04182984

• Early warning system for cognitive impairment in diabetes

  This study is testing a new way to spot early signs of brain changes in people with type 2 diabetes and mild cognitive impairment to help prevent further cognitive decline.

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT02420470

Quick answers

How many clinical trials run by Tang-Du Hospital are recruiting right now?

36, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 13, Phase 1/2: 4, Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →